SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Martine Dhilly, Stéphane Guillouet, Delphine patin, Fabien Fillesoye, Ahmed Abbas, Fabienne Gourand, Olivier Tirel, Françoise Galateau, Eric T. MacKenzie, Charles Dumontet, Michel Leporrier, Louisa Barré, 2-[18F]Fludarabine, a Novel Positron Emission Tomography (PET) Tracer for Imaging Lymphoma: a Micro-PET Study in Murine Models, Molecular Imaging and Biology, 2014, 16, 1, 118

    CrossRef

  2. 2
    Tomáš Papajík, Miroslav Mysliveček, Renata Urbanová, Eva Buriánková, Zuzana Kapitáňová, Vít Procházka, Peter Turcsányi, Radim Formánek, Lenka Henzlová, Patrik Flodr, Marie Jarošová, Karel Indrák, 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation, Leukemia & Lymphoma, 2014, 55, 2, 314

    CrossRef

  3. 3
    Lale Kostakoglu, Bruce D. Cheson, Current role of FDG PET/CT in lymphoma, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 5, 1004

    CrossRef

  4. 4
    Christelle Tychyj-Pinel, Fabien Ricard, Michael Fulham, Marion Fournier, Michel Meignan, Thierry Lamy, Pierre Vera, Gilles Salles, Judith Trotman, PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 3, 408

    CrossRef

  5. 5
    Inas El-Najjar, Silvia Montoto, Amy McDowell, Janet Matthews, John Gribben, Teresa A. Szyszko, The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma, Nuclear Medicine Communications, 2014, 35, 3, 311

    CrossRef

  6. 6
    Panayiotis D. Ziakas, Loukia S. Poulou, Loukas Thanos, Towards integrating positron emission tomography for work-up of patients with Sjögren's syndrome and associated lymphomas, Autoimmunity Reviews, 2014, 13, 3, 327

    CrossRef

  7. 7
    Michael J. Conte, Deborah A. Bowen, Gregory A. Wiseman, Kari G. Rabe, Susan L. Slager, Susan M. Schwager, Timothy G. Call, David S. Viswanatha, Clive S. Zent, Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, Leukemia & Lymphoma, 2014, 1

    CrossRef

  8. 8
    Sally Fiona Barrington, Nabegh George Mikhaeel, When should FDG-PET be used in the modern management of lymphoma?, British Journal of Haematology, 2014, 164, 3
  9. 9
    John F. Seymour, Judith Trotman, Michael S. Hofman, Evaluating the place of 18-fluoro-2-deoxy-d-glucose positron emission tomography scanning in primary staging and beyond in patients with follicular lymphoma, Leukemia & Lymphoma, 2013, 54, 10, 2093

    CrossRef

  10. 10
    Aisheng Dong, Yang Wang, Hui Dong, Jing Gong, Chao Cheng, Changjing Zuo, Jianping Lu, Inflammatory Myofibroblastic Tumor, Clinical Nuclear Medicine, 2013, 1

    CrossRef

  11. 11
    Masashi Nakadate, Katsuya Yoshida, Akihiro Ishii, Masayuki Koizumi, Naobumi Tochigi, Yoshio Suzuki, Yoshiharu Ryu, Tassei Nakagawa, Isao Umehara, Hitoshi Shibuya, Is 18F-FDG PET/CT Useful for Distinguishing Between Primary Thyroid Lymphoma and Chronic Thyroiditis?, Clinical Nuclear Medicine, 2013, 38, 9, 709

    CrossRef

  12. 12
    Karim E. Abou-Nassar, Ann Vanderplas, Jonathan W. Friedberg, Gregory A. Abel, Joyce Niland, Maria A. Rodriguez, Myron S. Czuczman, Michael Millenson, Allison Crosby, Leo I. Gordon, Andrew D. Zelenetz, Mark Kaminski, Ann S. Lacasce, Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1–2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database, Leukemia & Lymphoma, 2013, 54, 10, 2155

    CrossRef

  13. 13
    D E Spaner, E Lee, Y Shi, F Wen, Y Li, S Tung, L McCaw, K Wong, H Gary-Gouy, A Dalloul, R Ceddia, R Gorzcynski, PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia, Leukemia, 2013, 27, 5, 1090

    CrossRef

  14. 14
    Sho Hangai, Fumihiko Nakamura, Yasuhiko Kamikubo, Motoshi Ichikawa, Hirobumi Suzuki, Shuntaro Yoshida, Atsuo Yamada, Yutaka Takazawa, Masashi Fukayama, Kazuhiko Koike, Mineo Kurokawa, Primary gastrointestinal follicular lymphoma with histological transformation, Annals of Hematology, 2013, 92, 7, 993

    CrossRef

  15. 15
    Pier Luigi Zinzani, Monia Marchetti, Atto Billio, Giovanni Barosi, Angelo Michele Carella, Mario Lazzarino, Maurizio Martelli, Alessandro Rambaldi, Luigi Rigacci, Corrado Tarella, Umberto Vitolo, Sante Tura, SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma, American Journal of Hematology, 2013, 88, 3
  16. 16
    S. Luminari, I. Biasoli, L. Arcaini, A. Versari, C. Rusconi, F. Merli, M. Spina, A. J. M. Ferreri, P. L. Zinzani, A. Gallamini, S. Mastronardi, C. Boccomini, G. Gaidano, A. M. D'Arco, F. Di Raimondo, A. M. Carella, A. Santoro, P. Musto, M. Federico, The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi, Annals of Oncology, 2013, 24, 8, 2108

    CrossRef

  17. You have free access to this content17
    Oguz Akin, Sandra B. Brennan, D. David Dershaw, Michelle S. Ginsberg, Marc J. Gollub, Heiko Schöder, David M. Panicek, Hedvig Hricak, Advances in oncologic imaging, CA: A Cancer Journal for Clinicians, 2012, 62, 6
  18. 18
    Takayoshi Shinya, Soichiro Fujii, Shoji Asakura, Toshitaka Taniguchi, Kotaro Yoshio, Aierken Alafate, Shuhei Sato, Tadashi Yoshino, Susumu Kanazawa, Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma, Annals of Nuclear Medicine, 2012, 26, 8, 616

    CrossRef

  19. 19
    Egesta Lopci, Lucia Zanoni, Arturo Chiti, Cristina Fonti, Ivan Santi, Pier Luigi Zinzani, Stefano Fanti, FDG PET/CT predictive role in follicular lymphoma, European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39, 5, 864

    CrossRef

  20. 20
    C. Bodet-Milin, T. Eugène, T. Gastinne, E. Frampas, S. Le Gouill, F. Kraeber-Bodéré, FDG-PET in Follicular Lymphoma Management, Journal of Oncology, 2012, 2012, 1

    CrossRef

  21. You have free access to this content21
    Christopher McNamara, John Davies, Martin Dyer, Peter Hoskin, Tim Illidge, Matthew Lyttelton, Robert Marcus, Silvia Montoto, Alan Ramsay, Wai Lup Wong, Kint Ardeshna, Guidelines on the investigation and management of follicular lymphoma, British Journal of Haematology, 2012, 156, 4
  22. 22
    Arutselvan Natarajan, Gayatri Gowrishankar, Carsten H. Nielsen, Sen Wang, Andrei Iagaru, Michael L. Goris, Sanjiv Sam Gambhir, Positron Emission Tomography of 64Cu-DOTA-Rituximab in a Transgenic Mouse Model Expressing Human CD20 for Clinical Translation to Image NHL, Molecular Imaging and Biology, 2012, 14, 5, 608

    CrossRef

  23. 23
    Silvia Taralli, Maria Lucia Calcagni, Vittoria Rufini, Luca Laurenti, Simona Sica, Patrizia Chiusolo, Giuseppe Leone, Alessandro Giordano, Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients, Annals of Nuclear Medicine, 2012, 26, 9, 764

    CrossRef

  24. 24
    Eugen C. Minca, Saurin R. Popat, Manpreet K. Chadha, Mihai Merzianu, Small Lymphocytic Lymphoma Obscuring Microscopic Tonsillar Squamous Cell Carcinoma: an Unknown Occurrence with a Known Primary, Head and Neck Pathology, 2012, 6, 1, 125

    CrossRef

  25. 25
    Dushyant V. Sahani, Pietro A. Bonaffini, Onofrio A. Catalano, Alexander R. Guimaraes, Michael A. Blake, State-of-the-Art PET/CT of the Pancreas: Current Role and Emerging Indications, RadioGraphics, 2012, 32, 4, 1133

    CrossRef

  26. 26
    M.S. Hofman, R.J. Hicks, Imaging in follicular NHL, Best Practice & Research Clinical Haematology, 2011, 24, 2, 165

    CrossRef

  27. 27
    Tal Grenader, Eliahu Golomb, Anthony Goldberg, Lymph Node Collision Tumor of Non-Small Cell Lung Carcinoma and Chronic Lymphocytic Leukemia, Onkologie, 2011, 34, 6, 329

    CrossRef

  28. 28
    Malou A Vermoolen, Marie José Kersten, Rob Fijnheer, Maarten S van Leeuwen, Thomas C Kwee, Rutger AJ Nievelstein, Magnetic resonance imaging of malignant lymphoma, Expert Review of Hematology, 2011, 4, 2, 161

    CrossRef

  29. 29
    Tomáš Papajík, Miroslav Mysliveček, Zuzana Šedová, Eva Buriánková, Vít Procházka, Pavel Koranda, Luděk Raida, Zuzana Kubová, Miroslava Palová, Ladislava Kučerová, Patrik Flodr, Jiří Jarkovský, Ladislav Dušek, Karel Indrák, Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin’s lymphoma, European Journal of Haematology, 2011, 86, 1
  30. 30
    Hideyuki Nishiofuku, Shigeru Matsushima, Yoshitaka Inaba, Hidekazu Yamaura, Yozo Sato, Yasuo Morishima, Kimihiko Kichikawa, Cellular Density Evaluation for Malignant Lymphoma Using Equivalent Cross-Relaxation Rate Imaging - Initial Experience, Korean Journal of Radiology, 2010, 11, 3, 327

    CrossRef

  31. 31
    Ludovic Dortz, Sophie Guibert, Sahar Bayat, Anne Devillers, Roch Houot, Yan Rolland, Marc Cuggia, Florence Jeune, Haïfa Bahri, Marie-Luce Barge, Thierry Lamy, Etienne Garin, Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 12, 2307

    CrossRef

  32. 32
    Masahiro Okada, Norihide Sato, Kazunari Ishii, Kaname Matsumura, Makoto Hosono, Takamichi Murakami, FDG PET/CT versus CT, MR Imaging, and67Ga Scintigraphy in the Posttherapy Evaluation of Malignant Lymphoma1, RadioGraphics, 2010, 30, 4, 939

    CrossRef

  33. 33
    Shuji Yamamoto, Hiroshi Nakase, Kouhei Yamashita, Minoru Matsuura, Mariko Takada, Chiharu Kawanami, Tsutomu Chiba, Gastrointestinal follicular lymphoma: review of the literature, Journal of Gastroenterology, 2010, 45, 4, 370

    CrossRef

  34. 34
    Ukihide Tateishi, Takashi Terauchi, Tomio Inoue, Kensei Tobinai, Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: PET/CT, Abdominal Imaging, 2010, 35, 2, 232

    CrossRef

  35. 35
    Dimitris J. Apostolopoulos, Nikolaos I. Papandrianos, Argiris Symeonidis, Tryfon Spyridonidis, Sotiria Alexiou, Petros Zampakis, Christos Savvopoulos, Pavlos J. Vassilakos, Panagiota Matsouka, Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate, Annals of Nuclear Medicine, 2010, 24, 9, 639

    CrossRef

  36. 36
    Hiroyuki Sakurai, Toshio Oyama, A Case of Synchronous Primary Lung Cancer and Follicular Lymphoma, Haigan, 2009, 49, 3, 309

    CrossRef

  37. 37
    Ruth Pettengell, Advanced-Stage Follicular Lymphoma in the Rituximab Era, Drugs, 2009, 69, 13, 1727

    CrossRef

  38. 38
    L. Le Dortz, S. de Guibert, A. Devillers, Y. Rolland, S. Bayat, F. Prigent, H. Bahri, T. Hervouet, T. Lamy, E. Garin, Apport de la tomographie à émission de positons au 18F-fluorodéoxyglucose dans la prise en charge des lymphomes folliculaires, Médecine Nucléaire, 2009, 33, 6, 363

    CrossRef

  39. 39
    Barbara J. Fueger, Kristen Yeom, Johannes Czernin, James W. Sayre, Michael E. Phelps, Martin S. Allen-Auerbach, Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin’s Lymphoma, Molecular Imaging and Biology, 2009, 11, 4, 269

    CrossRef

  40. 40
    Bingfeng Tang, Jozef Malysz, Vonda Douglas-Nikitin, Richard Zekman, Regina Heather Wong, Ishmael Jaiyesimi, Ching-yee Oliver Wong, Correlating Metabolic Activity with Cellular Proliferation in Follicular Lymphomas, Molecular Imaging and Biology, 2009, 11, 5, 296

    CrossRef

  41. 41
    Sonali Rao, Amelia Langston, James R. Galt, Raghuveer K. Halkar, Extramedullary Acute Myeloid Leukemia and the Use of FDG-PET/CT, Clinical Nuclear Medicine, 2009, 34, 6, 365

    CrossRef

  42. 42
    Hani Mawardi, Corey Cutler, Nathaniel Treister, Medical management update: Non-Hodgkin lymphoma, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2009, 107, 1, e19

    CrossRef

  43. 43
    Andrew M. Scott, Dishan H. Gunawardana, Joseph Wong, Ian Kirkwood, Rodney J. Hicks, Ivan Ho Shon, Jayne E. Ramshaw, Peter Robins, Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study, European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36, 3, 347

    CrossRef

  44. 44
    Drew A. Torigian, Parvati Ramchandani, CT and MRI of the Whole Body, 2009,

    CrossRef

  45. 45
    Lale Kostakoglu, [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Lymphomas, Clinical Lymphoma and Myeloma, 2008, 8, 5, 273

    CrossRef

  46. 46
    T. C. Kwee, R. M. Kwee, R. A. J. Nievelstein, Imaging in staging of malignant lymphoma: a systematic review, Blood, 2008, 111, 2, 504

    CrossRef

  47. 47
    Andrew Wirth, Marcus Foo, John F. Seymour, Michael P. MacManus, Rodney J. Hicks, Impact of [18F] Fluorodeoxyglucose Positron Emission Tomography on Staging and Management of Early-Stage Follicular Non-Hodgkin Lymphoma, International Journal of Radiation Oncology*Biology*Physics, 2008, 71, 1, 213

    CrossRef

  48. 48
    Elise A. Chong, Drew A. Torigian, Anthony R. Mato, Lisa H. Downs, Stephen J. Schuster, Marginal Zone Lymphoma Involving Subcutaneous Fat, Clinical Nuclear Medicine, 2008, 33, 10, 692

    CrossRef

  49. 49
    Bruce D. Cheson, New Staging and Response Criteria for Non-Hodgkin Lymphoma and Hodgkin Lymphoma, Radiologic Clinics of North America, 2008, 46, 2, 213

    CrossRef

  50. 50
    Tsuyoshi Morimoto, Ukihide Tateishi, Tetsuo Maeda, Yasuaki Arai, Yasuo Nakajima, E. Edmund Kim, Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: Comparison of integrated PET/CT with or without contrast enhancement, European Journal of Radiology, 2008, 67, 3, 508

    CrossRef

  51. 51
    Bruce D. Cheson, Staging and Evaluation of the Patient with Lymphoma, Hematology/Oncology Clinics of North America, 2008, 22, 5, 825

    CrossRef

  52. 52
    Martin Allen-Auerbach, Sven de Vos, Johannes Czernin, The Impact of Fluorodeoxyglucose–Positron Emission Tomography in Primary Staging and Patient Management in Lymphoma Patients, Radiologic Clinics of North America, 2008, 46, 2, 199

    CrossRef

  53. 53
    Andrea Janikova, Karol Bolcak, Tomas Pavlik, Jiri Mayer, Zdenek Kral, Value of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Follicular Lymphoma: The End of a Dilemma?, Clinical Lymphoma and Myeloma, 2008, 8, 5, 287

    CrossRef

  54. 54
    Positron Emission Tomography-Computed Tomography, 2008,

    CrossRef

  55. 55
    G. A. Salles, Clinical Features, Prognosis and Treatment of Follicular Lymphoma, Hematology, 2007, 2007, 1, 216

    CrossRef

  56. 56
    Current Awareness in Hematological Oncology, Hematological Oncology, 2007, 25, 1
  57. 57
    J. G. Gribben, How I treat indolent lymphoma, Blood, 2007, 109, 11, 4617

    CrossRef

  58. 58
    Marion Baudard, Frederic Comte, Anne Marie Conge, Denis Mariano-Goulart, Bernard Klein, Jean François Rossi, Importance of [18F]fluorodeoxyglucose-positron emission tomography scanning for the monitoring of responses to immunotherapy in follicular lymphoma, Leukemia & Lymphoma, 2007, 48, 2, 381

    CrossRef

  59. 59
    M. Hoffmann, M. Raderer, Malignant B-cell Lymphoma, WHO Classification and the Respective 18F-fluoro-deoxy-glucose Positron Emission Tomography Results, Imaging Decisions MRI, 2007, 10, 4
  60. 60
    Andrew Wirth, PET for follicular lymphoma: A work in progress!, Leukemia & Lymphoma, 2007, 48, 8, 1463

    CrossRef

  61. 61
    Shrinivas Bishu, Joanna M. Quigley, Shreenath R. Bishu, Sarah M. Olsasky, Richard A. Stem, Valerie K. Shostrom, Karen P. Holdeman, Subash Paknikar, James O. Armitage, Jordan H. Hankins, Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma, Leukemia & Lymphoma, 2007, 48, 8, 1548

    CrossRef

  62. 62
    Ronan Swords, John Bruzzi, Francis Giles, Recent advances in the diagnosis and therapy of richter’s syndrome, Medical Oncology, 2007, 24, 1, 17

    CrossRef

  63. 63
    Bruce D. Cheson, The International Harmonization Project for Response Criteria in Lymphoma Clinical Trials, Hematology/Oncology Clinics of North America, 2007, 21, 5, 841

    CrossRef

  64. 64
    K. Namberger, R. Greil, The Role of Imaging in Malignant Lymphoma: A Critical View on PET Scanning in Current Clinical Practice, Imaging Decisions MRI, 2007, 10, 4
  65. 65
    Norifumi Tsukamoto, Masaru Kojima, Masatoshi Hasegawa, Noboru Oriuchi, Takafumi Matsushima, Akihiko Yokohama, Takayuki Saitoh, Hiroshi Handa, Keigo Endo, Hirokazu Murakami, The usefulness of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and a comparison of 18F-FDG-pet with 67gallium scintigraphy in the evaluation of lymphoma, Cancer, 2007, 110, 3